解释血清CK-MB活性测定免疫抑制试验需要特别照顾患者的肿瘤病理。

{"title":"解释血清CK-MB活性测定免疫抑制试验需要特别照顾患者的肿瘤病理。","authors":"M V Bor","doi":"10.1007/BF02874142","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":77180,"journal":{"name":"International journal of clinical & laboratory research","volume":"29 3","pages":"133-4"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02874142","citationCount":"1","resultStr":"{\"title\":\"Interpretation of serum CK-MB activity measured by immunoinhibition assay requires special care in patients with neoplastic pathology.\",\"authors\":\"M V Bor\",\"doi\":\"10.1007/BF02874142\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":77180,\"journal\":{\"name\":\"International journal of clinical & laboratory research\",\"volume\":\"29 3\",\"pages\":\"133-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/BF02874142\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of clinical & laboratory research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/BF02874142\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical & laboratory research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF02874142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}